We are live on
!
Find out more
IC
Inverness Counsel Portfolio holdings
AUM
$1.8B
1-Year Est. Return
9.9%
This Fund
S&P 500
This Quarter
Est. Return
+0.36%
1 Year Est. Return
-9.9%
3 Year Est. Return
+53.95%
5 Year Est. Return
+113.88%
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
-$2.2M
(-0.17%)
Cap. Flow
+$4.85M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
42.86%
Holding
102
New
5
Increased
23
Reduced
41
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$24.6M |
| 2 |
Progressive
PGR
|
+$19.5M |
| 3 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$12.5M |
| 4 |
RTX Corp
RTX
|
+$10.1M |
| 5 |
Home Depot
HD
|
+$9.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$16M |
| 2 |
Moody's
MCO
|
+$13.5M |
| 3 |
Walt Disney
DIS
|
+$10.7M |
| 4 |
TJX Companies
TJX
|
+$9.63M |
| 5 |
AbbVie
ABBV
|
+$8.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Industrials | 17.6% |
| 3 | Healthcare | 13.74% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Roper Technologies
ROP
$39.5B
| $135M | 10.48% |
790,378
-13,255
| -2% | -$2.32M |
|
2
Carlisle Companies
CSL
$14.7B
| $100M | 7.77% |
946,605
-25,765
| -3% | -$2.62M |
|
3
Dover
DOV
$27.9B
| $69.7M | 5.41% |
1,244,090
+148,579
| +14% | +$8.01M |
|
4
GE Aerospace
GE
$382B
| $40.1M | 3.12% |
266,061
-664
| -0.2% | -$96.9K |
|
5
Meta Platforms (Facebook)
META
$1.5T
| $39.4M | 3.06% |
344,428
-24,968
| -7% | -$2.88M |
|
6
Kraft Heinz
KHC
$30.3B
| $34.7M | 2.7% |
392,110
-19,874
| -5% | -$1.63M |
|
7
Alphabet (Google) Class A
GOOGL
$4.23T
| $34.4M | 2.67% |
978,580
+56,120
| +6% | +$2.06M |
|
8
Adobe
ADBE
$105B
| $34M | 2.64% |
354,906
-10,480
| -3% | -$1.01M |
|
9
Microsoft
MSFT
$3.68T
| $32.5M | 2.53% |
635,565
-18,393
| -3% | -$956K |
|
10
CVS Health
CVS
$124B
| $31.9M | 2.48% |
333,121
-5,945
| -2% | -$592K |
|
11
Ecolab
ECL
$77.4B
| $31.6M | 2.46% |
266,720
-16,990
| -6% | -$1.98M |
|
12
O'Reilly Automotive
ORLY
$73.7B
| $28.9M | 2.24% |
1,598,400
-12,975
| -0.8% | -$229K |
|
|
13
Home Depot
HD
$338B
| $28.7M | 2.23% |
224,643
+73,087
| +48% | +$9.66M |
|
14
Costco
COST
$426B
| $28.1M | 2.18% |
178,962
+15,624
| +10% | +$2.37M |
|
15
ExxonMobil
XOM
$658B
| $26.9M | 2.09% |
286,851
-17,552
| -6% | -$1.55M |
|
16
Procter & Gamble
PG
$336B
| $26.8M | 2.08% |
316,709
-8,903
| -3% | -$731K |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $25.4M | 1.98% |
110,016
+9,265
| +9% | +$2.14M |
|
|
18
Progressive
PGR
$122B
| $24.8M | 1.93% |
740,881
+589,391
| +389% | +$19.5M |
|
|
SCHW
19
Charles Schwab
SCHW
$192B
| $24.4M | 1.9% |
965,350
-14,335
| -1% | -$407K |
|
20
US Bancorp
USB
$102B
| $24.3M | 1.89% |
603,311
-2,763
| -0.5% | -$115K |
|
21
Apple
AAPL
$4.46T
| $24.3M | 1.89% |
1,017,840
-166,548
| -14% | -$4.14M |
|
22
PNC Financial Services
PNC
$103B
| $24M | 1.86% |
294,374
+2,925
| +1% | +$251K |
|
|
CELG
23
DELISTED
Celgene Corp
CELG
| $23.5M | 1.82% |
+237,842
| New | +$24.6M |
|
24
UnitedHealth
UNH
$361B
| $23.3M | 1.81% |
164,713
+489
| +0.3% | +$65.2K |
|
|
25
Walt Disney
DIS
$184B
| $22.9M | 1.78% |
233,896
-106,557
| -31% | -$10.7M |
|
Similar funds
SCA
ACM
RHBC
BDF
DY
WFA
CA
RIG
Inverness Counsel's Q2 2016 Portfolio in Review
As of Q2 2016, Inverness Counsel held 102 positions worth $1.29B, down 0.17% from $1.29B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Inverness Counsel's Q2 2016 filing shows 5 new, 23 increased, 41 reduced and 6 closed positions. Its largest new stake was Celgene Corp: 237,842 shares worth $23.5M. The largest sale was Gilead Sciences, an estimated $16M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.
- Inverness Counsel's largest Q2 2016 buy was Celgene Corp: 237,842 shares worth $23.5M.
- Inverness Counsel added most to Progressive in Q2 2016, an estimated $19.5M increase.
- Inverness Counsel's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $16M.
- Inverness Counsel fully exited Moody's in Q2 2016, selling an estimated $13.5M.
- Inverness Counsel's ten largest holdings make up 43% of its $1.29B portfolio in Q2 2016.
- Inverness Counsel opened 5 new positions and closed 6 in Q2 2016.
- Inverness Counsel's portfolio value fell 0.17% quarter-over-quarter to $1.29B.
Based on Inverness Counsel's 13F filing for Q2 2016, filed 4 Aug 2016.